Explore

Innovations

                                        
                                    Published
                            
                Healthcare & Pharmaceuticals
            
Treatment for Multiple Myeloma
                This technology is a SR-18465 compound, which is an osteoclastogenesis matrix metalloproteinase 13 (MMP-13) highly specific inhibitor for the treatment of multiple myeloma.
            
By
                            Florida Atlantic University
                        
Reference Number  
                07444
            
Last Update  
                 Apr 15, 2021
            
                                    Published
                            
                Medical
            
Wound Repair
                The invention can be used for general protease inhibitor designed to target different classes of metalloproteases. Easy scale-up in the manufacturing of the protein therapeutic.
            
By
                            University of Massachusetts, Amherst
                        
Reference Number  
                02519
            
Last Update  
                 Nov 15, 2021
            
        Do you have an innovative technology, product or service?Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.

View all

Gain innovation insights and shape the future with LEO. Sign up for our newsletter today!